Synovial sarcoma future or investigational therapies: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
== Future or Investigational Therapies == | |||
Further investigation of the molecular mechanisms underlying SYT-SSX function will likely lead to not only a better understanding of this disease but improved diagnostic and treatment tools for this tumor. | Further investigation of the molecular mechanisms underlying SYT-SSX function will likely lead to not only a better understanding of this disease but improved diagnostic and treatment tools for this tumor. | ||
==References== | ==References== | ||
Revision as of 14:53, 10 September 2012
|
Synovial sarcoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Synovial sarcoma future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Synovial sarcoma future or investigational therapies |
|
Synovial sarcoma future or investigational therapies in the news |
|
Blogs on Synovial sarcoma future or investigational therapies |
|
Risk calculators and risk factors for Synovial sarcoma future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Future or Investigational Therapies
Further investigation of the molecular mechanisms underlying SYT-SSX function will likely lead to not only a better understanding of this disease but improved diagnostic and treatment tools for this tumor.